|Last Price$193.47||Day Change (%)-1.35%|
|Open Price$195.47||Day Change ($)-2.65|
|Day Range192.60–196.25||52-Week Range127.69–213.33|
As of Wed 3/4/2015 3:25:00 PM | USD
Illumina Launches TruSight HLA Solution
Illumina Accelerator Secures $40 Million Boost Capital to Back New Graduates
Caren Mason Appointed President & CEO of STAAR Surgical Company
Charting a sluggish, but bullish, S&P 500 -2-
Illumina ILMN reported second-quarter results Tuesday that beat our expectations, and we plan to raise our fair value estimate by several dollars per share. Revenue totaled $84.5 million for the quarter, a 103% increase from the year-ago period, which prompted the firm to significantly raise its ...
Research and Markets: Diagnostics Partnering Terms and Agreements Report 2015
Continued technology advancements and market expansion support Illumina's narrow moat.
TrialReach Raises $13.5M Series B Led by Smedvig Capital
UPDATE: U.S. markets spike from major -2-
Competitive advantages have improved for Mead Johnson, while De La Rue's moat was downgraded to narrow and POSCO was deemed a no-moat company.